Non-invasive Prenatal Testing (NIPT) Market Size, Share & COVID-19 Impact Analysis, By Product (Instruments and Consumables & Reagents), By Technology (Next Generation Sequencing (NGS), Microarray, Polymerase Chain Reaction (PCR), and Rolling Circular Amplification), By End-User (Hospitals and Clinical Laboratories), and Regional Forecast, 2023-2030

ATTRIBUTE

DETAILS

Study Period

2019-2030

Base Year

2022

Estimated Year

2023

Forecast Period

2023-2030

Historical Period

2019-2021

Growth Rate

CAGR of 17.8% from 2023-2030

Unit

Value (USD billion)

Segmentation

By Product, Technology, End User, and Region

By Product

• Consumables & Reagents
• Instruments

By Technology

• Next Generation Sequencing (NGS)
• Microarray
• Polymerase Chain Reaction (PCR)
• Rolling Circular Amplification

By End User

• Hospitals
• Clinical Laboratories

By Region

• North America (By Product, By Technology, By End User, and By Country)
  • U.S. (By Product)
  • Canada (By Product)
• Europe (By Product, By Technology, By End User, and By Country)
  • U.K. (By Product)
  • Germany (By Product)
  • France (By Product)
  • Italy (By Product)
  • Spain (By Product)
  • Rest of Europe (By Product)

• Asia Pacific (By Product, By Technology, By End User, and By Country)

• • China (By Product)
  • Japan (By Product)
  • India (By Product)
  • Australia (By Product)
  • Southeast Asia (By Product)
  • Rest of Asia Pacific (By Product)
• Latin America (By Product, By Technology, By End User, and By Country)
  • Brazil (By Product)
  • Mexico (By Product)
  • Rest of Latin America (By Product)
• Middle East & Africa (By Product, By Technology, By End User, and By Country)
  • GCC (By Product)
  • South Africa (By Product)
  • Rest of Middle East & Africa (By Product)